Guangdong Taienkang Pharmaceutical Co., Ltd. (SHE:301263)
16.10
-0.97 (-5.68%)
At close: Nov 20, 2026
| Market Cap | 8.07B -35.8% |
| Revenue (ttm) | 681.75M +1.1% |
| Net Income | 28.71M +23.3% |
| EPS | 0.06 +26.3% |
| Shares Out | 501.09M |
| PE Ratio | 275.95 |
| Forward PE | n/a |
| Dividend | 0.04 (0.26%) |
| Ex-Dividend Date | Jun 1, 2026 |
| Volume | 4,703,171 |
| Open | 16.85 |
| Previous Close | 17.07 |
| Day's Range | 16.10 - 16.88 |
| 52-Week Range | 16.10 - 29.78 |
| Beta | 0.29 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 27, 2026 |